[Ursodeoxycholic acid: A therapeutic niche in an internist's practice].

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Терапевтический архив

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/terarkh201587484-90PMID 26087640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Структурно-функциональные изменения миокарда у больных с алкогольным циррозом печени

  2016cited by this paper
• The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.

  2014cited by this paper
• Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment.

  2014cited by this paper
• Статины и неалкогольная жировая болезнь печени

  2014cited by this paper
• Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

  2013cited by this paper
• The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review

  2013cited by this paper
• From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights.

  2013cited by this paper
• Therapy of gallstone disease: What it was, what it is, what it will be.

  2012cited by this paper
• Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode

  2012cited by this paper
• Ursodeoxycholic acid for primary biliary cirrhosis.

  2012cited by this paper
• Risk factors and prediction of long-term outcome in primary biliary cirrhosis.

  2011cited by this paper
• Bile acids for primary sclerosing cholangitis.

  2011cited by this paper
• Progress in the genetics of primary biliary cirrhosis.

  2011cited by this paper
• High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind, randomized, placebo‐controlled trial

  2010cited by this paper
• Bile acids for liver-transplanted patients.

  2010cited by this paper
• Возможности клинического применения современных фторхинолонов при операции синус-лифтинг и дентальной имплантации

  2009cited by this paper
• Ядерные рецепторы и метаболизм ксенобиотиков

  2009cited by this paper
• Pharmacologic therapy of non-alcoholic steatohepatitis.

  2009cited by this paper
• Нарушения липидного обмена при псориатической болезни

  2009cited by this paper
• Ursodeoxycholic acid in primary sclerosing cholangitis: meta‐analysis of randomized controlled trials

  2009cited by this paper
• High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cited by this paper
• A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients.

  2009cited by this paper
• Ursodeoxycholic acid for primary biliary cirrhosis.

  2008cited by this paper
• High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2007cited by this paper
• Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.

  2007cited by this paper
• Treatment of nonalcoholic fatty liver disease.

  2006cited by this paper
• Long-Term Effects of Mid-Dose Ursodeoxycholic Acid in Primary Biliary Cirrhosis: A Meta-analysis of Randomized Controlled Trials

  2006cited by this paper
• The Farnesoid X Receptor A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism

  2005cited by this paper
• Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

  2005cited by this paper
• Bile acids for liver-transplanted patients.

  2005cited by this paper
• Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.

  2005influential reference
• The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

  2005cited by this paper
• Efecto del ácido ursodesoxicólico combinado con estatinas para el tratamiento de la hipercolesterolemia: ensayo clínico prospectivo

  2004cited by this paper
• [Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial].

  2004cited by this paper
• Ursodeoxycholic acid — adverse effects and drug interactions

  2003cited by this paper
• Treatment of nonalcoholic fatty liver disease

  2003cited by this paper
• Autoimmune pancreatitis successfully treated with ursodeoxycholic acid.

  2002cited by this paper
• [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].

  2002cited by this paper
• Use of ursodeoxycholic acid in patients with liver disease

  2002cited by this paper
• A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.

  2001cited by this paper
• Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

  2001cited by this paper
• Ursodeoxycholic acid in the treatment of alcoholic liver disease

  2000cited by this paper
• Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

  1999cited by this paper
• Ursodeoxycholic Acid Improves Liver Tests in Chronic Hepatitis

  1999cited by this paper
• From a choleretic to an immunomodulator: Historical review of ursodeoxycholic acid as a medicament

  1998cited by this paper
• The ursodeoxycholic acid story in primary biliary cirrhosis.

  1995cited by this paper
• Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

  1994cited by this paper
• Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.

  1994cited by this paper
• Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

  1994cited by this paper
• Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores.

  1993cited by this paper
• Efficacy of bile acid therapy for gallstone dissolution: a meta‐analysis of randomized trials

  1993cited by this paper
• Comparative binding of bile acids to serum lipoproteins and albumin.

  1993cited by this paper
• Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial

  1992cited by this paper
• Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease

  1992cited by this paper
• Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30‐month pilot study

  1991cited by this paper
• Ursodeoxycholic acid–induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

  1990cited by this paper
• Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.

  1990cited by this paper
• Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

  1990cited by this paper
• Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.

  1989cited by this paper
• Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.

  1988cited by this paper
• Ursodeoxycholic Acid for Primary Biliary Cirrhosis?

  1987cited by this paper
• Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

  1987cited by this paper
• Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up

  1985cited by this paper
• Dissolution of cholesterol gallstones by chenodeoxycholic acid.

  1972cited by this paper
• Syntheses of Ursodesoxycholic Acid and Its Conjugated Bile Acid

  1954cited by this paper
• A Large-scale, Multicentre, Double-blind Trial of Ursodeoxycholic Acid in Patients with Chronic Hepatitis C

  year unknowncited by this paper

• Ursodeoxycholic Acid is a Multifunctional Agent in Gastroenterology

  2025cites this paper
• Role of bile acids in atherogenesis: review

  2024cites this paper
• Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece?

  2024cites this paper
• Targeted use of hepatoprotectors for the treatment of various stages of non-alcoholic fatty liver disease (fatty degeneration of the liver according to ICD 10) and associated comorbid conditions; tables for medical use

  2024cites this paper
• The study of the possibility of drug dissolution of gallbladder calculi

  2020cites this paper